272 related articles for article (PubMed ID: 10078605)
1. Induction of specific cell-mediated immunity in mice by oral immunization with Salmonella expressing Onchocerca volvulus glutathione S-transferase.
Catmull J; Wilson ME; Kirchhoff LV; Metwali A; Donelson JE
Vaccine; 1999 Jan; 17(1):31-9. PubMed ID: 10078605
[TBL] [Abstract][Full Text] [Related]
2. Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.
Abraham D; Leon O; Leon S; Lustigman S
Infect Immun; 2001 Jan; 69(1):262-70. PubMed ID: 11119514
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human immune responses to the cytosolic superoxide dismutase and glutathione S-transferase from Onchocerca volvulus.
Brattig NW; Henkle-Dührsen KH; Hounkpatin S; Liebau E; Kruppa TF; Zipfel PF
Trop Med Int Health; 1997 Aug; 2(8):788-98. PubMed ID: 9294549
[TBL] [Abstract][Full Text] [Related]
4. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
[TBL] [Abstract][Full Text] [Related]
5. HIV gp120-specific cell-mediated immune responses in mice after oral immunization with recombinant Salmonella.
Berggren RE; Wunderlich A; Ziegler E; Schleicher M; Duke RC; Looney D; Fang FC
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):489-95. PubMed ID: 8548327
[TBL] [Abstract][Full Text] [Related]
6. Oral vaccination with attenuated Salmonella enterica serovar Typhimurium expressing Cap protein of PCV2 and its immunogenicity in mouse and swine models.
Xu XG; Zhao HN; Zhang Q; Ding L; Li ZC; Li W; Wu HY; Chuang KP; Tong DW; Liu HJ
Vet Microbiol; 2012 Jun; 157(3-4):294-303. PubMed ID: 22326539
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune response in mice and dogs induced by a recombinant Echinococcus multilocularis antigen produced by a Salmonella typhimurium vaccine strain.
Gottstein B; Müller N; Cryz SJ; Vogel M; Tanner I; Seebeck T
Parasite Immunol; 1990 Mar; 12(2):163-74. PubMed ID: 2181385
[TBL] [Abstract][Full Text] [Related]
8. Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.
MacDonald AJ; Tawe W; Leon O; Cao L; Liu J; Oksov Y; Abraham D; Lustigman S
Parasite Immunol; 2004 Jan; 26(1):53-62. PubMed ID: 15198646
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to a recombinant attenuated Salmonella typhimurium strain expressing a Taenia solium oncosphere antigen TSOL18.
Ding J; Zheng Y; Wang Y; Dou Y; Chen X; Zhu X; Wang S; Zhang S; Liu Z; Hou J; Zhai J; Yan H; Luo X; Cai X
Comp Immunol Microbiol Infect Dis; 2013 Jan; 36(1):17-23. PubMed ID: 23219684
[TBL] [Abstract][Full Text] [Related]
10. pOVEX vector: prokaryotic expression and purification of onchocerciasis vaccine candidate antigens as fusion proteins with the 24 kD Onchocerca volvulus glutathione S-transferase.
Liebau E; Spillner E; Henkle-Dührsen K
Trop Med Int Health; 1997 Jul; 2(7):691-4. PubMed ID: 9270737
[TBL] [Abstract][Full Text] [Related]
11. Trichinella spiralis: intranasal immunization with attenuated Salmonella enterica carrying a gp43 antigen-derived 30mer epitope elicits protection in BALB/c mice.
Pompa-Mera EN; Yépez-Mulia L; Ocaña-Mondragón A; García-Zepeda EA; Ortega-Pierres G; González-Bonilla CR
Exp Parasitol; 2011 Dec; 129(4):393-401. PubMed ID: 21907709
[TBL] [Abstract][Full Text] [Related]
12. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
[TBL] [Abstract][Full Text] [Related]
13. Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines.
Mastroeni P; Villarreal-Ramos B; Hormaeche CE
Microb Pathog; 1992 Dec; 13(6):477-91. PubMed ID: 1363824
[TBL] [Abstract][Full Text] [Related]
14. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
15. Regulated Delayed
Su H; Liu Q; Wang S; Curtiss R; Kong Q
Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
[No Abstract] [Full Text] [Related]
16. Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans.
McCarthy JS; Wieseman M; Tropea J; Kaslow D; Abraham D; Lustigman S; Tuan R; Guderian RH; Nutman TB
Infect Immun; 2002 Feb; 70(2):851-8. PubMed ID: 11796620
[TBL] [Abstract][Full Text] [Related]
17. DNA immunisation with Onchocerca volvulus chitinase induces partial protection against challenge infection with L3 larvae in mice.
Harrison RA; Wu Y; Egerton G; Bianco AE
Vaccine; 1999 Nov; 18(7-8):647-55. PubMed ID: 10547424
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
George PJ; Hess JA; Jain S; Patton JB; Zhan T; Tricoche N; Zhan B; Bottazzi ME; Hotez PJ; Abraham D; Lustigman S
PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007730. PubMed ID: 31525197
[TBL] [Abstract][Full Text] [Related]
19. Recombinant, attenuated Salmonella typhimurium stimulate lymphoproliferative responses to SIV capsid antigen in rhesus macaques.
Steger KK; Valentine PJ; Heffron F; So M; Pauza CD
Vaccine; 1999 Feb; 17(7-8):923-32. PubMed ID: 10067699
[TBL] [Abstract][Full Text] [Related]
20. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
Huang Y; Hajishengallis G; Michalek SM
Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
